Altre lingue IO Biotech, Inc.

Azioni

IOBT

US4497781090

Mercato chiuso - Nasdaq Altri mercati azionari 21:59:49 30/05/2024			Variaz. 5gg	Var. 1 gen.
1,24 ^USD	+0,81%		-6,06%	-34,04%

15/05	IO BIOTECH, INC. : giudizio positivo da HC Wainwright	ZM
14/05	IO Biotech, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

IO Biotech to Present at Jefferies Global Healthcare Conference	23/05
IO Biotech : Corporate Deck May 2024	17/05
IO Biotech : Corporate Deck May 2024	14/05
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights	14/05
IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
IO Biotech, Inc. Announces Resignation of Jack Nielsen as Member of the Board of Directors	26/04
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
IO Biotech : Corporate Deck April 2024	17/04
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness	15/04
IO Biotech Announces Marjan Shamsaei as Senior Vice President	15/04
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103	09/04
IO Biotech, Inc. Presents New Data At Aacr 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, Io102-Io103	09/04
IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer	05/04
IO Biotech, Inc. Appoints Faiçal Miyara as Chief Business Officer	05/04
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	06/03
IO Biotech Announces Acceptance of Abstract to Be Presented at the 2024 American Association for Cancer Research Annual Meeting	06/03
IO Biotech : Corporate Deck March 2024	05/03
IO Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
IO Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results	05/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue IO Biotech, Inc.

Azioni

IOBT

US4497781090

Altre lingue

Filtri